Showing results (1021-1030 of 1,896) with videos related to
Sort By:
Pageof 190
Endokrynologia Polska|January 1, 1989
[The role of bombesin in regulating thyrotropin secretion in rats. In vivo studies]Z K Krowicki, H Sadowska-KrowickaEndokrynologia Polska|May 11, 2019
New insights into clinical features, karyotypes, and age at diagnosis in women with Turner syndromeJakub Frelich, Tomasz Irzyniec, Katarzyna Lepska, et al.Endokrynologia Polska|October 14, 2021
Thyroglobulin measurements in washouts of fine-needle aspiration biopsy in the monitoring of patients with differentiated thyroid carcinomaElwira Bakuła-Zalewska, Agnieszka Żyłka, Joanna Długosińska, et al.Endokrynologia Polska|October 14, 2021
Orbital decompression for thyroid eye disease: surgical treatment outcomes in endocrinological assessmentOlga Jurek-Matusiak, Eliza Brożek-Mądry, Helena Jastrzębska, et al.Endokrynologia Polska|October 14, 2021
Liver dysfunction and hypoglycaemia as presentations of hypopituitarism in a childSara Fonseca, Tiago Magalhães, Beatriz Teixeira, et al.Endokrynologia Polska|July 6, 2019
Efficacy and safety of high-dose long-acting repeatable octreotide as monotherapy or in combination with pegvisomant or cabergoline in patients with acromegaly not adequately controlled by conventional regimens: results of an open-label, multicentre studyAnnamaria Colao, Wojciech Zgliczyński, Jan Komorowski, et al.Endokrynologia Polska|July 6, 2019
Multiple endocrine neoplasia type 1 in Poland: a two-centre experiencePrzemysław Soczomski, Beata Jurecka-Lubieniecka, Natalia Rogozik, et al.Endokrynologia Polska|July 6, 2019
Amiodarone-induced thyroid dysfunction in the developmental period: prenatally, in childhood, and adolescence - case reports and a review of the literatureAleksandra Furtak, Anna Wędrychowicz, Anna Kalicka-Kasperczyk, et al.Endokrynologia Polska|April 5, 2022
Free triiodothyronine and free thyroxine hormone levels in relation to breast cancer risk: a meta-analysisZhengwu Lei, Bin Zeng, Lina Wu, et al.Endokrynologia Polska|April 5, 2022
Imeglimin: a new antidiabetic drug with potential future in the treatment of patients with type 2 diabetesMariusz Nowak, Władysław GrzeszczakPageof 190